Study #2022-0968
Systemic therapy of open-label prophylactic Pravastatin or Pentoxifylline/Tocopherol prevention of lymphedema advancing to eventual fibrosis: an interventional registry-embedded bayesian randomized trial for radiation sequelae (STOP4-LATE-FIBROSE)
MD Anderson Study Status
Enrolling
Treatment Agent
Pravastatin, Pentoxifylline, Tocopherol
Description
To learn if pentoxifylline and vitamin E or pravastatin can reduce radiation-induced lymphedema/fibrosis.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Lymphedema, Fibrosis
Study phase:
Phase II
Physician name:
Clifton Fuller
Department:
Radiation Oncology
For general questions about clinical trials:
1-844-338-0349
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.